Unlock instant, AI-driven research and patent intelligence for your innovation.

Colacea-4-O-acetyl-Gly-Asp-Val salt, its synthesis, activity and application

A curcumin, -val-obzl technology, applied in the field of biomedicine, can solve the problems of strontium ranelate with large side effects, large clinical dosage, and poor solubility

Active Publication Date: 2022-08-05
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to poor solubility, the clinical dose of strontium ranelate is large
Due to the large clinical dose, the side effects of strontium ranelate are large

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Colacea-4-O-acetyl-Gly-Asp-Val salt, its synthesis, activity and application
  • Colacea-4-O-acetyl-Gly-Asp-Val salt, its synthesis, activity and application
  • Colacea-4-O-acetyl-Gly-Asp-Val salt, its synthesis, activity and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Example 1 Preparation of 3-methoxy-4-(benzyl acetateoxy)benzaldehyde (1)

[0017] Dissolve 15.2 g (100 mmol) of vanillin in 100 mL of anhydrous tetrahydrofuran, add 6.9 g (50 mmol) of anhydrous potassium carbonate, stir at room temperature for 2 h, after the solution changes from pale yellow to milky white turbid state, add 15 mL (76 mmol) of benzyl bromoacetate Ester, stirred at 60 ° C for 48 h. The reaction mixture was filtered, the filtrate was concentrated under reduced pressure, and the residue was dissolved in 100 mL of ethyl acetate. The resulting solution was prepared with 5% KHSO 4 Washed with aqueous solution (30mL×3) and saturated NaCl aqueous solution (30mL×3), washed with anhydrous Na 2 SO 4 Dry for 12 h, filter, and concentrate the filtrate under reduced pressure. The residue is placed in anhydrous ether to precipitate 27.6 g (92%) of the title compound as colorless crystals. ESI-MS(m / e):301[M+H] + .

Embodiment 2

[0018] Example 2 Preparation of 6-(4-hydroxy-3-methoxyphenyl)-5,6-hexene-2,4-dione (2)

[0019] Disperse 9.9 mL (97.0 mmol) of acetylacetone in 50 mL of anhydrous ethyl acetate, add 4.6 g (66.7 mmol) of boron anhydride, and stir at 60 °C for 1 h. After that, 5.06 g (33.3 mmol) of vanillin and 9 mL (33.5 mmol) of tri-n-butyl borate were added successively, and the mixture was stirred at 80° C. for 0.5 h. After that, add 34 mL of n-butylamine in anhydrous ethyl acetate solution (1 / 10, v / v), and stir at 80 °C for 2 h. Cool to 60 ℃, add 34 mL of dilute hydrochloric acid (1 M), stir for 0.5 h, and cool to room temperature. Filter, filtrate with 5% KHSO 4 Washed with aqueous solution (30mL×3) and saturated NaCl aqueous solution (30mL×3), washed with anhydrous Na 2 SO 4 It was dried for 12 h, filtered, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to obtain 3.1 g (40%) of the title compound as a pale yellow ...

Embodiment 3

[0020] Example 3 Preparation of 1-(4-hydroxy-3-methoxyphenyl)-7-(4-oxyacetylbenzyl ester-3-methoxyphenyl)-1,6-heptadiene-3, 5-Dione (3)

[0021] 5 g (21.4 mmol) of 6-(4-hydroxy-3-methoxyphenyl)-5,6-hexene-2,4-dione (2), 3 g (42.8 mmol) of boronic anhydride and 30 mL of Water and ethyl acetate suspension. The suspension was stirred at 60 °C for 1 h, 6.4 g (21.4 mmol) of 3-methoxy-4-(benzyl acetateoxy)benzaldehyde and 5.7 mL (21.2 mmol) of tri-n-butyl borate were added, and the mixture was stirred at 80 °C for 0.5 h , Add 21 mL of n-butylamine in anhydrous ethyl acetate (1 / 10, v / v), and stir for 2h. Cool to 60 ℃, add 42.7 mL of dilute hydrochloric acid (1 M), stir for 0.5 h, and cool to room temperature. Filter, filtrate with 5% KHSO 4 Washed with aqueous solution (30mL×3) and saturated NaCl aqueous solution (30mL×3), washed with anhydrous Na 2 SO 4 It was dried for 12 h, filtered, the filtrate was concentrated under reduced pressure, and the residue was purified by silica...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses curcumin-4-OCH 2 CO-Arg-Gly-Asp-Val strontium, discloses its preparation method, and discloses its anti-osteoporosis activity, so the invention discloses its application in the preparation of anti-osteoporosis drugs.

Description

technical field [0001] The present invention relates to curcumin-4-OCH 2 CO-Arg-Gly-Asp-Val strontium, relates to its preparation method, and relates to its anti-osteoporosis activity. Therefore, the present invention relates to its application in the preparation of anti-osteoporosis drugs. The invention belongs to the field of biomedicine. technical background [0002] The World Health Organization predicts that the number of elderly people will reach 2 billion by 2050. This means that population ageing is an important issue facing the world. Osteoporosis is one of the diseases that plague the elderly. Considering the population base, osteoporosis poses a particularly serious threat to the health of the elderly in my country. Curcumin is a natural product extracted from the rhizome of the plant turmeric with a wide range of pharmacological activities. Such as anti-tumor, anti-thrombotic and anti-inflammatory. However, curcumin has low bioavailability and poor water s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K5/11C07K1/02A61K47/64A61K31/12A61K33/24A61P19/10
CPCC07K5/1019A61K47/64A61K31/12A61K33/24A61P19/10A61K2300/00
Inventor 赵明张筱宜彭师奇李辉
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES